Brown Shipley & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.5M Buy
4,750
+33
+0.7% +$38.9K 2.64% 12
2026
Q2
$5.66M Buy
4,717
+75
+2% +$76.6K 2.93% 11
2026
Q1
$4.27M Buy
4,642
+21
+0.5% +$21.3K 2.56% 14
2025
Q4
$4.97M Sell
4,621
-153
-3% -$146K 2.66% 14
2025
Q3
$3.64M Sell
4,774
-99
-2% -$73.7K 1.92% 15
2025
Q2
$3.8M Sell
4,873
-259
-5% -$201K 2.09% 15
2025
Q1
$4.24M Buy
5,132
+65
+1% +$54.1K 2.4% 15
2024
Q4
$3.91M Buy
5,067
+3,523
+228% +$2.92M 1.94% 19
2024
Q3
$1.37M Buy
1,544
+142
+10% +$128K 0.67% 25
2024
Q2
$1.27M Sell
1,402
-44
-3% -$35.2K 0.57% 26
2024
Q1
$1.1M Sell
1,446
-2,331
-62% -$1.66M 0.35% 35
2023
Q4
$2.2M Sell
3,777
-7,104
-65% -$4.15M 1.09% 24
2023
Q3
$5.84M Buy
10,881
+1,091
+11% +$562K 3.22% 11
2023
Q2
$4.59M Buy
9,790
+975
+11% +$409K 1.88% 20
2023
Q1
$3.03M Buy
+8,815
New +$2.97M 1.95% 19

Other funds holding LLY

Brown Shipley & Co's LLY Position: Q3 2026 in Review

Brown Shipley & Co increased its Eli Lilly (LLY) stake by 0.7% in Q3 2026, buying an estimated $38.9K and bringing the position to 4,750 shares worth $5.5M. The position accounts for 2.64% of the portfolio, ranked #12.

Brown Shipley & Co first reported a position in LLY in Q1 2023 and has held it in 15 quarters since. The position peaked at $5.84M in Q3 2023. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Brown Shipley & Co held 4,750 shares of Eli Lilly worth $5.5M as of Q3 2026.
  • Brown Shipley & Co bought 33 Eli Lilly shares in Q3 2026, an estimated $38.9K.
  • Eli Lilly made up 2.64% of Brown Shipley & Co's portfolio in Q3 2026, its #12 holding.
  • Brown Shipley & Co first reported a position in Eli Lilly in Q1 2023 and has held it in 15 quarters since.
  • Brown Shipley & Co's Eli Lilly position peaked at $5.84M in Q3 2023.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Brown Shipley & Co's 13F filing for Q3 2026, filed 9 Oct 2026.